The 21 CFR 207.69 requirements and duties, how the U.S. Agent differs from the Official Contact and importer, and why responsiveness is non-negotiable.
A U.S. Agent is a person or company located in the United States that a foreign drug establishment names as its point of contact with FDA. Under 21 CFR 207.69, foreign drug establishments — prescription, OTC, API, or contract manufacturers, repackers, and relabelers — must designate a single U.S. Agent as part of drug establishment registration.
| Role | What it is | Where it can be |
|---|---|---|
| U.S. Agent (207.69(b)) | The foreign establishment's FDA communications link | Must be physically in the U.S. |
| Official Contact (207.69(a)) | The establishment's designated contact for its registration/listing | Anywhere — including abroad |
| Importer of record | The party responsible for the import entry & its data | U.S.-based |
The role rhymes across FDA's programs, but the framework differs — and a company in more than one category needs a separate agent for each:
FDA Registration Assistance provides independent, responsive U.S. Agent representation for foreign drug, pharmaceutical, and OTC establishments — a stable physical U.S. address, prompt handling of FDA communications (including emergencies), inspection-scheduling support, and coordination with your registration, listing, and annual renewal.
Contact us at info@fdaregistrationassistance.com or call +1 (928) 275-8333 for a quote. An independent compliance firm serving 1,000+ companies across 135+ countries, with 15+ years of experience.
A U.S. Agent is a person or company physically located in the United States that a foreign drug (or OTC) establishment designates as its communications link with FDA. Under 21 CFR 207.69, the U.S. Agent reviews, routes, and responds to all FDA communications — including emergency communications — answers questions about the establishment's imported drugs, and assists FDA in scheduling inspections. FDA providing information to the U.S. Agent counts as providing it to the foreign establishment.
Every foreign drug establishment that manufactures, repacks, relabels, or processes drugs for the U.S. — prescription, OTC, API, or contract-manufactured — must designate a single U.S. Agent as part of its FDA drug establishment registration (21 CFR 207.69). Domestic (U.S.-based) establishments don't need one. OTC drug establishments are covered exactly like prescription-drug establishments.
The U.S. Agent must reside in, or maintain a place of business in, the United States — and under 21 CFR 207.69 it explicitly may not be a mailbox, an answering machine or service, or any place where the agent isn't physically present. Each foreign establishment designates a single U.S. Agent (one agent can represent many establishments), the agent must consent to serve, and it's recorded in the registration. It must be genuinely reachable, including for emergencies.
21 CFR 207.69(b) lists the duties: (1) reviewing, disseminating, routing, and responding to all FDA communications, including emergency communications; (2) responding to questions about the establishment's drugs that are imported or offered for import; and (3) assisting FDA in scheduling inspections of the foreign establishment. And (4): if FDA can't reach the foreign registrant directly or expeditiously, it may deliver information to the U.S. Agent — and that delivery is equivalent to delivering it to the foreign establishment.
No — they're two distinct roles under 21 CFR 207.69. The Official Contact (207.69(a)) is the establishment's designated contact for its registration and listing and can be located anywhere, including abroad. The U.S. Agent (207.69(b)) is specifically the U.S.-based liaison required for foreign establishments. A foreign establishment needs both. They can be different people, and mixing them up is a common registration error.
The role is similar, but the framework differs. Drug establishments are governed by 21 CFR Part 207 (the U.S. Agent under 207.69); food facilities by 21 CFR Part 1 (the U.S. Agent under 1.227); devices by Part 807. Drug registration — and the agent designation with it — is renewed annually (Oct–Dec), whereas food registration is biennial. A company handling both food and drugs generally needs separate registrations, each with its own U.S. Agent designation.
Yes. Foreign OTC drug manufacturers register their establishment and list their products just like prescription-drug makers, and must designate a U.S. Agent under 21 CFR 207.69. The OTC pathway differs (monograph compliance and a Drug Facts label rather than an NDA/ANDA), but the U.S. Agent requirement is the same.
A foreign drug establishment's registration isn't complete without a valid U.S. Agent — and without an active registration, its drugs are misbranded under FD&C §502(o) and can be refused and detained at the border. Just as damaging, an unresponsive agent means FDA's communications still legally "land" (delivery to the agent counts as delivery to you) while your establishment never sees them — so deadlines pass unmet.
No. The U.S. Agent's role is regulatory communication with FDA about the establishment — not customs entry, freight, or logistics. The importer of record handles the import entry and its data, and (for the safety program on the food side) the FSVP importer is a separate role. A single provider may offer several of these functions, but they're distinct responsibilities — don't assume your U.S. Agent is your importer.
Yes — assisting FDA in scheduling inspections of the foreign establishment is one of the agent's defined duties (21 CFR 207.69(b)(3)). Drug facilities are subject to cGMP inspections (21 CFR Parts 210 and 211), and a responsive agent that can quickly reach the facility to coordinate scheduling and relay FDA's requirements is genuinely useful when an inspection is arranged.
It's permitted — a U.S.-based distributor or other party can serve — but many foreign drug manufacturers prefer an independent regulatory provider. A distributor's interests can diverge from yours, and if the relationship ends you lose your agent and risk your registration. An independent U.S. Agent focused on compliance offers stable, conflict-free representation and reliable responsiveness to FDA, including for emergencies.
Yes. A foreign establishment can update its registration to designate a new U.S. Agent, and the new agent must consent. Because drug registration is renewed annually, the U.S. Agent is confirmed and maintained with each October–December cycle — which is also a natural point to move away from an unresponsive agent to a reliable one.
No. Designating a U.S. Agent (and registering) only identifies your establishment to FDA; it is not approval of any product. Claiming a drug is "FDA-approved" because you're registered or have a U.S. Agent is misbranding. Approval is a separate, product-level status (NDA/ANDA, or OTC monograph compliance). The U.S. Agent keeps your registration functioning; it doesn't confer approval.
Generally your establishment's legal name and physical address, the operations performed, your DUNS/FEI, official contact details, and your product/listing information. We're designated as your U.S. Agent in the registration, confirm the designation with FDA, and then handle FDA communications, import questions, and inspection-scheduling coordination on your behalf going forward.
We provide independent, responsive U.S. Agent representation for foreign drug, pharmaceutical, and OTC establishments — a stable physical U.S. address, prompt handling of FDA communications (including emergencies), inspection-scheduling support, and coordination with your registration, listing, and annual renewal. We're an independent compliance firm (not affiliated with FDA), BBB-accredited, serving 1,000+ companies across 135+ countries over 15+ years. Contact info@fdaregistrationassistance.com or +1 (928) 275-8333 for a quote.